Clinical Trial

Dietary Fiber on the Gut Microbiome and HDL Particles

Study Description

The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects

The objective of this project is to conduct a randomized-order, double-blinded cross-over trial in 20 participants to test the effects of a dietary fiber formulation on gut microbiota composition and short chain fatty acid production, lipid profiles, glucose sensitivity, intestinal permeability, overall gut health, and markers of inflammation.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Dietary Fiber

Dietary fiber will be given in a powder form to mix with a beverage of one's choice.

Placebo

Placebo will be given in a powder form to mix with a beverage of one's choice.

Additional Information

Official Study Title

The Effects of Dietary Fiber on the Gut Microbiome and HDL Particles of Human Subjects

Clinical Trial ID

NCT03785860

ParticipAid ID

bW6mWa